PerkinElmer Provides Comprehensive Solutions for Collaboration on NIH Roadmap Initiative; Reagents, Instrumentation and Application Expertise Expected to Help Drive Development of New Therapies

PerkinElmer Inc. (NYSE: PKI) today announced that it has entered a collaborative agreement with the National Institute of Health’s National Chemical Genomics Center (NCGC) to provide reagents, instrumentation and scientific support for identifying small molecules, which can be valuable tools for understanding important cellular events involved in health and disease, potentially leading to drug discovery.

Source: PerkinElmer, Inc.